Chenlei Wen

1.5k total citations
26 papers, 622 citations indexed

About

Chenlei Wen is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Chenlei Wen has authored 26 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Chenlei Wen's work include Pancreatic and Hepatic Oncology Research (10 papers), RNA modifications and cancer (5 papers) and Cancer Genomics and Diagnostics (4 papers). Chenlei Wen is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), RNA modifications and cancer (5 papers) and Cancer Genomics and Diagnostics (4 papers). Chenlei Wen collaborates with scholars based in China, Italy and Taiwan. Chenlei Wen's co-authors include Chenghong Peng, Minmin Shi, Xinjing Wang, Zhen Huo, Hongzhe Li, Xiaomei Tang, Baiyong Shen, Xiaxing Deng, Qian Zhan and Hao Chen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Chenlei Wen

26 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenlei Wen China 11 434 401 131 62 48 26 622
Huilin Jin China 15 276 0.6× 140 0.3× 100 0.8× 49 0.8× 39 0.8× 26 508
Wojciech Pigłowski Poland 14 277 0.6× 116 0.3× 96 0.7× 82 1.3× 31 0.6× 23 459
Xueke Qian China 8 276 0.6× 258 0.6× 132 1.0× 20 0.3× 79 1.6× 14 502
Lijuan Qu China 13 263 0.6× 119 0.3× 61 0.5× 64 1.0× 60 1.3× 34 453
Felix Prinz Austria 12 461 1.1× 439 1.1× 92 0.7× 51 0.8× 47 1.0× 19 627
Xiaodong Yu China 12 294 0.7× 249 0.6× 80 0.6× 50 0.8× 55 1.1× 26 449
Changzhu Duan China 9 624 1.4× 456 1.1× 62 0.5× 31 0.5× 30 0.6× 24 742
Ruifen Dong China 15 419 1.0× 360 0.9× 111 0.8× 44 0.7× 57 1.2× 22 685

Countries citing papers authored by Chenlei Wen

Since Specialization
Citations

This map shows the geographic impact of Chenlei Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenlei Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenlei Wen more than expected).

Fields of papers citing papers by Chenlei Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenlei Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenlei Wen. The network helps show where Chenlei Wen may publish in the future.

Co-authorship network of co-authors of Chenlei Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Chenlei Wen. A scholar is included among the top collaborators of Chenlei Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenlei Wen. Chenlei Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Xiaohan, Yuntao Yang, Ke Jiang, et al.. (2025). FNDC4 Drives Metastasis and Immune Evasion in Pancreatic Cancer. Cancer Research. 86(2). 349–366. 1 indexed citations
2.
Zhao, Yaru, Chenlei Wen, Qi Wang, et al.. (2025). Use of the Malaria Protein VAR2CSA for the Detection of Small Extracellular Vesicles to Diagnose Adenocarcinoma. Journal of Extracellular Vesicles. 14(4). e70067–e70067. 1 indexed citations
3.
Yu, Qian, Ke Jiang, Siyu Ma, et al.. (2025). Elesclomol-copper combination synergistically targets mitochondrial metabolism in cancer stem cells to overcome chemoresistance in PDAC. Molecular Therapy. 33(12). 6160–6177. 2 indexed citations
4.
Shan, Qungang, Yaping Zhuang, Jingjing Liu, et al.. (2025). Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell axis in MHC-I deficient pancreatic cancer. Cancer Letters. 617. 217620–217620. 3 indexed citations
5.
Zou, Siyi, Lei Zhang, Cen Jiang, et al.. (2024). Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes. Cancer Letters. 599. 217134–217134. 6 indexed citations
6.
Zhan, Qian, Chenlei Wen, Siyi Zou, et al.. (2024). Perioperative fuzuloparib plus mFOLFIRINOX for resectable pancreatic adenocarcinoma: A phase 1 study.. Journal of Clinical Oncology. 42(16_suppl). 4163–4163. 2 indexed citations
7.
Gao, Xia, Yang Liu, Shuyu Zhai, et al.. (2024). H19 promotes polarization and alternative splicing in tumor-associated macrophages, facilitating pancreatic cancer progression. Cancer Letters. 611. 217389–217389. 6 indexed citations
8.
Wu, Renfei, Jingwei Li, Alexandra Aicher, et al.. (2024). Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis‐Independent Mechanism. Advanced Science. 11(42). e2308990–e2308990. 10 indexed citations
9.
10.
Ai, Qi, Fanlu Li, Siyi Zou, et al.. (2023). Targeting KRASG12V mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors. Frontiers in Immunology. 14. 1161538–1161538. 8 indexed citations
11.
Zou, Siyi, Xinjing Wang, Haoda Chen, et al.. (2022). Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study. BMC Cancer. 22(1). 649–649. 6 indexed citations
12.
Liu, Yihao, Minmin Shi, Xingfeng He, et al.. (2022). LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma. Journal of Hematology & Oncology. 15(1). 52–52. 114 indexed citations
13.
Zhang, Zehui, Siyi Zou, Fanlu Li, et al.. (2021). A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer. Frontiers in Oncology. 11. 634881–634881. 13 indexed citations
14.
Wen, Chenlei, Xiaxing Deng, Song Xue, et al.. (2020). Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma. Cancer Medicine. 9(20). 7626–7636. 2 indexed citations
15.
Li, Hongzhe, Xinjing Wang, Chenlei Wen, et al.. (2017). Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Molecular Cancer. 16(1). 169–169. 192 indexed citations
16.
Wang, Xinjing, Jing Xie, Xiongxiong Lu, et al.. (2017). Melittin inhibits tumor growth and decreases resistance to gemcitabine by downregulating cholesterol pathway gene CLU in pancreatic ductal adenocarcinoma. Cancer Letters. 399. 1–9. 36 indexed citations
17.
Zhang, Yajing, Xiaomei Tang, Minmin Shi, Chenlei Wen, & Baiyong Shen. (2016). MiR-216a decreases MALAT1 expression, induces G2/M arrest and apoptosis in pancreatic cancer cells. Biochemical and Biophysical Research Communications. 483(2). 816–822. 54 indexed citations
18.
Wang, X., Jun Chu, Chenlei Wen, et al.. (2015). Functional characterization of TRAP1-like protein involved in modulating fibrotic processes mediated by TGF-β/Smad signaling in hypertrophic scar fibroblasts. Experimental Cell Research. 332(2). 202–211. 20 indexed citations
19.
Wang, Xinjing, Zhen Huo, Chenlei Wen, et al.. (2015). Robot-Assisted Middle Pancreatectomy for Elderly Patients: Our Initial Experience. Medical Science Monitor. 21. 2851–2860. 9 indexed citations
20.
Liu, Qin, Xinjing Wang, Baiyong Shen, et al.. (2014). Preliminary experience of the robot-assisted laparoscopic excision of a retroperitoneal mass: A case report. Oncology Letters. 8(6). 2399–2402. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huilin Jin Breakdown of academic impact, for papers by Wojciech Pigłowski Breakdown of academic impact, for papers by Xueke Qian Breakdown of academic impact, for papers by Lijuan Qu Breakdown of academic impact, for papers by Felix Prinz Breakdown of academic impact, for papers by Xiaodong Yu Breakdown of academic impact, for papers by Changzhu Duan Breakdown of academic impact, for papers by Ruifen Dong
Rankless by CCL
2026